Register Now

Drug Development for Arrhythmias: From Symptom Relief to Digital-Era Outcomes – Powered by Milestone Pharmaceuticals

September 18, 2026 | 03:55 PM (EDT) - 04:40 PM (EDT)

Share This event

Speakers
Brynn Dechert-Crooks
Pediatric Electrophysiology Nurse Practitioner
University of Michigan Congenital Heart Center
James Ip
Professor
Weill Cornell Medicine
Oliver Monfredi
Associate Professor of Medicine, Medical Director of the Complex Lead Management and Extraction Center of Excellence
University of Virginia
Andrea Russo, MD
Academic Chief, Division of Cardiology | Director, Cardiac Electrophysiology and Arrhythmia Services | Director, CCEP Fellowship
Cooper University Hospital
Kamala Tamirisa
Clinical Cardiac Electrophysiologist | Associate Professor of Internal Medicine in the Division of Cardiology | Director of Electrophysiology Research
UT Southwestern Medical Center
Moderator
Gregory Marcus
Cardiac Electrophysiologist & Professor of Medicine | Associate Chief of Cardiology for Research
Univ of California, San Francisco | JAMA

Drug Development for Arrhythmias: From Symptom Relief to Digital-Era Outcomes

Roundtable 1
September 18, 2026 | 03:55 PM (EDT) - 04:40 PM (EDT)

As the management of supraventricular tachycardia (SVT) evolves, advances in drug development, digital health technologies, and patient-centered care are reshaping the acute treatment pathway. This interactive
roundtable will explore how emerging therapies, innovative outpatient management strategies, and integration with wearable technologies may improve patient outcomes, optimize healthcare utilization, and redefine the transition from symptom relief to definitive arrhythmia care.

 

Powered by Milestone Pharamaceuticals

Milestone Pharmaceuticals